NEW YORK, Feb. 6, 2019 /PRNewswire/ -- Amplicare, the leading decision automation platform for pharmacies, today announced the addition of two new benefits to its suite of solutions aimed at helping pharmacists improve patient care and health outcomes in their communities.
In the efforts to combat the opioid epidemic in the United States, Naloxone remains an effective means of reversing the effects of an opioid overdose. Amplicare's platform now includes a capability that identifies pharmacy patients at a high risk of experiencing an opioid overdose in their household. Each opportunity is accompanied by tools to help pharmacists educate patients about Naloxone and its availability over-the-counter without a prescription.
Amplicare concurrently rolled out a similar capability to help pharmacists increase the rate of vaccinations, which is particularly timely in the current flu season. These updates provide pharmacists the opportunity to act on health interventions within their workflows, easily monitor progress, and manage the life cycle of these interventions.
"Community pharmacies are uniquely positioned in our healthcare system as the most accessible healthcare providers for patients, and they stand at the front lines of the fight against health crises," said Matt Johnson, Pharm.D., CEO of Amplicare. "As the role of pharmacists moves beyond dispensing prescriptions, our focus is to help them tap into the growing number of opportunities that exist in the clinical and business side of healthcare. These new benefits make it easier for them to mobilize vaccinations across their patient base and significantly reduce the life-threatening effects of opioid overdoses."
The introduction of these two new capabilities is in line with Amplicare's long-term goal of using technology to empower healthcare providers to better serve patients. Last year, the company rebranded from iMedicare to Amplicare as it expanded its solutions beyond Medicare plan comparisons to include tools to streamline workflows and identify opportunities for pharmacists to provide higher levels of care to patients.
Amplicare is the leading decision-automation platform that intelligently identifies relevant opportunities for healthcare providers to proactively improve patient care. The platform helps providers efficiently make an impact on their patients and communities, while providing better healthcare options for patients. With over 5,000 pharmacy subscribers, Amplicare delivers an unrivaled platform that increases patient retention, improves performance measures, grows and diversifies revenue streams, and enables providers to communicate with their patients more easily than ever before. For more information, visit www.amplicare.com.